Fenofibrate and extended-release niacin improve the endothelial protective effects of HDL in patients with metabolic syndrome

Vascul Pharmacol

6 July Jul 2015 10 years ago
  • Gomaraschi M, Ossoli A, Adorni MP, Damonte E, Niesor E, Veglia F, Franceschini G, Benghozi R, Calabresi L
QR Code
Treatment with fenofibrate or extended-release niacin  in patients with metabolic syndrome not only increased HDL-C levels but also improved the endothelial protective effects of HDL.